High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1

Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):118-129. doi: 10.1161/ATVBAHA.116.308435. Epub 2016 Nov 22.

Abstract

Objective: Plasma high-density lipoproteins (HDL) are potent antiatherogenic and anti-inflammatory particles. However, HDL particles are highly heterogenic in composition, and different HDL-mediated functions can be ascribed to different subclasses of HDL. Only a small HDL population contains apolipoprotein M (ApoM), which is the main plasma carrier of the bioactive lipid mediator sphingosine-1-phosphate (S1P). Vascular inflammation is modulated by S1P, but both pro- and anti-inflammatory roles have been ascribed to S1P. The goal of this study is to elucidate the role of ApoM and S1P in endothelial anti-inflammatory events related to HDL.

Approach and results: Aortic or brain human primary endothelial cells were challenged with tumor necrosis factor-α (TNF-α) as inflammatory stimuli. The presence of recombinant ApoM-bound S1P or ApoM-containing HDL reduced the abundance of adhesion molecules in the cell surface, whereas ApoM and ApoM-lacking HDL did not. Specifically, ApoM-bound S1P decreased vascular adhesion molecule-1 (VCAM-1) and E-selectin surface abundance but not intercellular adhesion molecule-1. Albumin, which is an alternative S1P carrier, was less efficient in inhibiting VCAM-1 than ApoM-bound S1P. The activation of the S1P receptor 1 was sufficient and required to promote anti-inflammation. Moreover, ApoM-bound S1P induced the rearrangement of the expression of S1P-related genes to counteract TNF-α. Functionally, HDL/ApoM/S1P limited monocyte adhesion to the endothelium and maintained endothelial barrier integrity under inflammatory conditions.

Conclusions: ApoM-bound S1P is a key component of HDL and is responsible for several HDL-associated protective functions in the endothelium, including regulation of adhesion molecule abundance, leukocyte-endothelial adhesion, and endothelial barrier.

Keywords: atherosclerosis; brain; endothelial cells; inflammation; lipoproteins; sphingosine.

MeSH terms

  • Anti-Inflammatory Agents / metabolism
  • Anti-Inflammatory Agents / pharmacology*
  • Apolipoproteins / metabolism
  • Apolipoproteins / pharmacology*
  • Apolipoproteins M
  • Capillary Permeability / drug effects
  • Cell Adhesion / drug effects
  • Cell Line
  • Coculture Techniques
  • Dose-Response Relationship, Drug
  • E-Selectin / metabolism
  • Human Umbilical Vein Endothelial Cells / drug effects*
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Human Umbilical Vein Endothelial Cells / pathology
  • Humans
  • Inflammation / metabolism
  • Inflammation / pathology
  • Inflammation / prevention & control*
  • Lipocalins / metabolism
  • Lipocalins / pharmacology*
  • Lipoproteins, HDL / metabolism
  • Lysophospholipids / metabolism
  • Lysophospholipids / pharmacology*
  • Monocytes / drug effects
  • Monocytes / metabolism
  • Protein Binding
  • Receptors, Lysosphingolipid / agonists*
  • Receptors, Lysosphingolipid / metabolism
  • Recombinant Proteins / pharmacology
  • Serum Albumin / metabolism
  • Serum Albumin / pharmacology
  • Signal Transduction / drug effects
  • Sphingosine / analogs & derivatives*
  • Sphingosine / metabolism
  • Sphingosine / pharmacology
  • Sphingosine-1-Phosphate Receptors
  • Time Factors
  • Tumor Necrosis Factor-alpha / pharmacology
  • Vascular Cell Adhesion Molecule-1 / metabolism

Substances

  • APOM protein, human
  • Anti-Inflammatory Agents
  • Apolipoproteins
  • Apolipoproteins M
  • E-Selectin
  • Lipocalins
  • Lipoproteins, HDL
  • Lysophospholipids
  • Receptors, Lysosphingolipid
  • Recombinant Proteins
  • S1PR1 protein, human
  • SELE protein, human
  • Serum Albumin
  • Sphingosine-1-Phosphate Receptors
  • Tumor Necrosis Factor-alpha
  • Vascular Cell Adhesion Molecule-1
  • sphingosine 1-phosphate
  • Sphingosine